Verici Dx plc (LON:VRCI – Get Free Report) shares were down 10.3% during trading on Friday . The company traded as low as GBX 5.16 ($0.06) and last traded at GBX 5.16 ($0.06). Approximately 1,575,868 shares were traded during mid-day trading, an increase of 20% from the average daily volume of 1,313,229 shares. The stock had previously closed at GBX 5.75 ($0.07).
Verici Dx Stock Performance
The company has a debt-to-equity ratio of 4.65, a current ratio of 4.54 and a quick ratio of 8.49. The company has a market capitalization of £12.50 million, a price-to-earnings ratio of -257.75 and a beta of 1.59. The stock has a 50-day moving average price of GBX 3.25 and a 200-day moving average price of GBX 5.27.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Articles
- Five stocks we like better than Verici Dx
- How to Read Stock Charts for Beginners
- Walgreens Stock Poised for a Rebound: Why Analysts Are Bullish
- 3 Healthcare Dividend Stocks to Buy
- Unstoppable Yields: 3 Blue-Chip Stocks to Maximize Returns
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Is Domino’s Recent Dip a Recipe for Long-Term Gains?
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
